Revolution Medicines Warrant Stock Performance

RVMDW Stock   1.68  0.03  1.75%   
Revolution Medicines holds a performance score of 12 on a scale of zero to a hundred. The company holds a Beta of 3.18, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Revolution Medicines will likely underperform. Use Revolution Medicines treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to analyze future returns on Revolution Medicines.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines Warrant are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental indicators, Revolution Medicines showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Disposition of 3000 shares by Mark Goldsmith of Revolution Medicines, at 75.0 subject to Rule 16b-3
11/25/2025
2
Disposition of 3104 shares by Jack Anders of Revolution Medicines at 77.0904 subject to Rule 16b-3
12/16/2025
3
Why Revolution Medicines Inc. Equity Warrant stock could outperform in 2025 - Quarterly Performance Summary Weekly Momentum Stock Picks -
12/19/2025
4
BofA Securities Maintains Revolution Medicines With Buy Rating, Raises Target Price to 98 -
01/06/2026
5
Why Revolution Medicines Stock Surged by 11 percent Today - Nasdaq
01/09/2026
6
Technical Analysis How much upside does Revolution Medicines Inc Equity Warrant have - 2025 Support Resistance Consistent Profit Trading Strategies - baoquankhu...
01/13/2026
7
Disposition of 908 shares by Cislini Jeff of Revolution Medicines at 115.6 subject to Rule 16b-3
01/21/2026
8
Macro Review Is TRUE showing insider buying - July 2025 Reactions Consistent Growth Equity Picks - baoquankhu1.vn
01/23/2026
9
48,000 RAS G12V cancer cases a year as Revolution Medicines trials new drug - Stock Titan
01/29/2026
10
Short Interest in Revolution Medicines, Inc. Drops By 91.3
02/11/2026
11
Acquisition by Mark Goldsmith of 20000 shares of Revolution Medicines at 4.09 subject to Rule 16b-3
02/17/2026
Begin Period Cash Flow696.1 M
Total Cashflows From Investing Activities-554.4 M

Revolution Medicines Relative Risk vs. Return Landscape

If you would invest  64.00  in Revolution Medicines Warrant on November 22, 2025 and sell it today you would earn a total of  104.00  from holding Revolution Medicines Warrant or generate 162.5% return on investment over 90 days. Revolution Medicines Warrant is currently producing 2.9667% returns and takes up 18.575% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Revolution, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Revolution Medicines is expected to generate 24.73 times more return on investment than the market. However, the company is 24.73 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Revolution Medicines Target Price Odds to finish over Current Price

The tendency of Revolution Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.68 90 days 1.68 
about 36.08
Based on a normal probability distribution, the odds of Revolution Medicines to move above the current price in 90 days from now is about 36.08 (This Revolution Medicines Warrant probability density function shows the probability of Revolution Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the stock has the beta coefficient of 3.18 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Revolution Medicines will likely underperform. In addition to that Revolution Medicines Warrant has an alpha of 3.2431, implying that it can generate a 3.24 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Revolution Medicines Price Density   
       Price  

Predictive Modules for Revolution Medicines

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Revolution Medicines. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revolution Medicines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.5220.11
Details
Intrinsic
Valuation
LowRealHigh
0.091.7920.38
Details
Naive
Forecast
LowNextHigh
0.062.7521.35
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.231.593.41
Details

Revolution Medicines Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Revolution Medicines is not an exception. The market had few large corrections towards the Revolution Medicines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Revolution Medicines Warrant, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Revolution Medicines within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.24
β
Beta against Dow Jones3.18
σ
Overall volatility
0.87
Ir
Information ratio 0.19

Revolution Medicines Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Revolution Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Revolution Medicines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Revolution Medicines is way too risky over 90 days horizon
Revolution Medicines may become a speculative penny stock
Revolution Medicines appears to be risky and price may revert if volatility continues
Revolution Medicines has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (880.48 M).
Revolution Medicines generates negative cash flow from operations
Revolution Medicines has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Mark Goldsmith of 20000 shares of Revolution Medicines at 4.09 subject to Rule 16b-3

Revolution Medicines Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Revolution Stock often depends not only on the future outlook of the current and potential Revolution Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Revolution Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding167.7 M
Cash And Short Term Investments2.3 B

Revolution Medicines Fundamentals Growth

Revolution Stock prices reflect investors' perceptions of the future prospects and financial health of Revolution Medicines, and Revolution Medicines fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Revolution Stock performance.

About Revolution Medicines Performance

Evaluating Revolution Medicines' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Revolution Medicines has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Revolution Medicines has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.22)(0.23)
Return On Capital Employed(0.26)(0.27)
Return On Assets(0.21)(0.22)
Return On Equity(0.24)(0.25)

Things to note about Revolution Medicines performance evaluation

Checking the ongoing alerts about Revolution Medicines for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Revolution Medicines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Revolution Medicines is way too risky over 90 days horizon
Revolution Medicines may become a speculative penny stock
Revolution Medicines appears to be risky and price may revert if volatility continues
Revolution Medicines has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (880.48 M).
Revolution Medicines generates negative cash flow from operations
Revolution Medicines has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Mark Goldsmith of 20000 shares of Revolution Medicines at 4.09 subject to Rule 16b-3
Evaluating Revolution Medicines' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Revolution Medicines' stock performance include:
  • Analyzing Revolution Medicines' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Revolution Medicines' stock is overvalued or undervalued compared to its peers.
  • Examining Revolution Medicines' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Revolution Medicines' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Revolution Medicines' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Revolution Medicines' stock. These opinions can provide insight into Revolution Medicines' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Revolution Medicines' stock performance is not an exact science, and many factors can impact Revolution Medicines' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.